Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » As the U.S. Opioid Crisis Rages On, Europe Continues to Hold Steady

    As the U.S. Opioid Crisis Rages On, Europe Continues to Hold Steady

    npsnps4 February 2019Updated:3 July 2024
    — Filed under: Focus
    Share
    Facebook Twitter LinkedIn Pinterest Email

    If you were to rate the biggest health issues in the United States, you’d find that opioid drug addiction has become one of the most significant epidemics of our lifetime, by far. Yet, despite the well-publicized fact that the crisis has grown steadily over the past decade, the nations of Europe continue to function without experiencing any appreciable opioid-related issues.

    The question arises: How can this be? A second question is: What can the U.S. learn from our attempts to deal with the problem thus far?

    Examining the American Opioid Crisis

    The origin of the American opioid crisis can be traced back to the end of the 20th century. Somewhere around the mid-to-late-1990s, large pharmaceutical companies began to produce massive amounts of opioids and to encourage healthcare providers to prescribe them for pain management.

    These companies, hungry for profits, promised the majority of patients wouldn’t become addicted and that opioids would be able to treat chronic pain effectively. Those claims have since been proved wrong.

    The National Institute on Drug Abuse estimates that 1.7 million Americans suffer from substance use disorders related to prescription opioid pain relievers. An estimated 652,000 suffer from heroin user disorder (but the conditions aren’t necessarily mutually exclusive).

    Despite the fact that 21 to 29 percent of patients who are prescribed opioids misuse them — and that 47,000 Americans die annually — doctors continue to write prescriptions for millions of patients each year.

    So the next time you hear the word “crisis” in conjunction with opioid abuse, don’t assume it’s just hyperbole. The epidemic is real, and it’s had catastrophic reverberations throughout the fabric of the nation.

    How Europe Avoided the Crisis

    Despite the fear on the part of health authorities that this problem might migrate across the Atlantic to Europe, it hasn’t happened yet. And it’s unlikely to happen at this point.

    Europe has avoided the crisis by thoughtful action that has worked, and doesn’t appear likely to fail. Doctors and other health professionals across the European continent have been less influenced by pharmaceutical lobbyists and seem to have developed a more well-rounded perspective on pain management.

    “Opioids provide important therapeutic options in bringing relief from acute and chronic pain,” acknowledges Professor Bart Morlion, head of a multidisciplinary pain center in Belgium. “We should not re-stigmatize these analgesics, but instead clarify how they can be used safely and effectively.'”

    To a degree, this is what most European countries have done. Opioids are employed sparingly and typically prescribed in lower dosages in conjunction with other natural treatments.

    This offers a stark contrast to the “pill mills” of the U.S., where patients can essentially get a prescription for various controlled substances with very few questions asked.

    What the U.S. Can Learn From European Nations

    The U.S. and Europe have normally shared approaches and tactics in health care. Many American lawmakers and public health officials are studying European practices and looking for a model for lowering the impact of opioid abuse in the states.

    Obviously, any solution to the opioid crisis begins and ends with how the drugs are prescribed, but it’s just as important for the U.S. to implement effective addiction-treatment solutions … which right now are few and far between.

    “We have 20 million people in this country struggling with cancer, and we have centers of excellence to treat cancer in every major metropolis in the country,” Dr. Anna Lembke states at InMyArea. “We have 20 to 40 million people, depending on how you count it, suffering from addiction, yet we have not a single real center of excellence the way that we do for cancer.”

    Perhaps America’s healthcare system could learn from Portugal, which has 40-plus publicly funded drug treatment facilities that treat more than 4,000 addicts (free of charge). Though it’s only a part of a larger plan, the focus on natural treatment has taken Portugal from Europe’s most drug-addicted nation to one of the cleanest in the world.

    Addicts need to know there’s a way out, and doctors shouldn’t feel pressured by drug manufacturers and pharmaceutical companies to continue prescribing opioids for pain management. As soon as the proper infrastructure is in place, the United States can begin to put a dent in this epidemic and enjoy more of the peace of mind that Europeans have experienced.

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    nps
    • Website

    Related Content

    Legal stamp - Image by Markus Spiske on Pexels

    UK Business Selling to The EU? When and Why Would You Have To Use An Apostille

    FuelsEurope

    REACH Senior Policy Advisor, FuelsEurope

    E3g logo

    Senior Policy Advisor, Clean Economy Europe,Third Generation Environmentalism E3G

    Pet dog at vet - Image by Tima Miroshnichenko on Pexels

    Green light for first EU rules to protect cats and dogs

    Rice sacks trade - Image by Thilina Alagiyawanna on Pexels

    Renewed EU trade instrument for development set for 2027

    Coachella Music Festival - Image by Benjamin Farren on Pexels

    Coachella 2026: The Festival That Turned a Tote Bag Into a Business Decision

    LATEST EU NEWS
    Pet dog at vet - Image by Tima Miroshnichenko on Pexels

    Green light for first EU rules to protect cats and dogs

    28 April 2026
    Rice sacks trade - Image by Thilina Alagiyawanna on Pexels

    Renewed EU trade instrument for development set for 2027

    28 April 2026
    Artificial intelligence - Image by Kohji Asakawa from Pixabay

    Brussels consults on Google measures to give Android users choice on AI services

    28 April 2026
    Car crash - Image by Rico Lob from Pixabay

    Road fatalities in the EU down 2.2 pct in 2024

    27 April 2026
    Costa - Zelensky - von der Leyen - Photo © European Union 2026

    EU Council finalises EUR 90 bn support loan to Ukraine

    23 April 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?